Neha Mehta-Shah
Non-Accredited Program Director-Medical Oncology · Washington University/B-JH/SLCH Consortium
Credentials: · · · · ·
History
PresentNon-Accredited -Medical Oncology · Washington University/B-JH/SLCH Consortium
- Present
Medical Oncology · Washington University/B-JH/SLCH Consortium
- 2012–2015
Hematology and Medical Oncology
- 2009–2012
Internal Medicine
2005–2009
Research
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2022 · 793 citations
Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla
Proceedings of the National Academy of Sciences of the United States of America · 2009 · 550 citations
Journal of Clinical Oncology · 2016 · 316 citations
- SH
30 papers
18 papers
- BK
16 papers
14 papers
- AM
13 papers
12 papers
11 papers
- SB
10 papers
Clinical trials
- 2026–2032
Principal investigator · Not yet recruiting · Phase 2
Washington University School of Medicine
- 2024–2029
Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
Principal investigator · Active not recruiting · Phase 1
Washington University School of Medicine
- 2023–2032
Principal investigator · Active not recruiting · Phase 1, Phase 2
Washington University School of Medicine
- 2021–2026
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)